Rutgers Law School student organizations hosted an online event, COVID’s Disparate Impact Panel. The program featured a discussion about the disparate impact of COVID-19 on minority communities and potential solutions for moving forward.
Rutgers Law School student organizations hosted an online event, COVID’s Disparate Impact Panel. The program featured a discussion about the disparate impact of COVID-19 on minority communities and potential solutions for moving forward.
The New Jersey Alliance for Clinical and Translational Science at Rutgers received a $5 million NIH grant to launch outreach campaigns and expand access to COVID-19 testing for underserved and vulnerable communities in New Jersey.
It’s been seven months since COVID-19 was declared a global pandemic. Rutgers students and faculty discuss the new normal.
As researchers race to develop a COVID-19 vaccine, two Rutgers Global Health Institute core faculty members discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials, and what a successful vaccine may mean.
Health officials can’t rely on a one-size-fits-all message when it comes to communicating with the public about a forthcoming COVID-19 vaccine, says Professor William Hallman, an experimental psychologist who uses scientific research to explore human behavior.
Human behavior is undermining efforts to curtail the spread of COVID-19, says School of Public Health dean and epidemiologist Perry N. Halkitis in a televised interview on CNN’s Erin Burnett OutFront nightly news program.
Global health involves many fields as well as local and international efforts. In an interview with the country’s largest South Asian radio station, Arpita Jindani of Rutgers Global Health Institute discusses COVID-19, food insecurity, community partnerships, and mobilizing volunteers.
While the overall rates of HIV/AIDS have decreased, the risk of infections within certain populations has surged. New Jersey Medical School faculty member Shobha Swaminathan is a clinical site leader for a vaccine trial that aims to provide HIV immunity for life.
The integration of cancer control into HIV settings in sub-Saharan Africa was the subject of Rutgers Global Health Institute director Richard Marlink’s presentation at the 23rd International AIDS Conference.
“Masks?” and “Mental Health” are the first two videos in a COVID-19 educational series being produced by the Rutgers Global Health Institute Student Council. Leading the project—and combining her passions, medicine and the arts—is committee co-chair Laura Palm, a medical school graduate and current doctoral student at Mason Gross School of the Arts.